Detection of prostate stem cell antigen expression in human prostate cancer using quantum-dot-based technology

Sensors (Switzerland)

Volumn 12, Issue 5, 2012, Pages 5461-5470

  Ruan, Yuan ^a   Yu, Weimin ^a   Cheng, Fan ^a   Zhang, Xiaobin ^a   Larré, Stéphane ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Fluorescence; Prostate cancer; Prostate stem cell antigen; Quantum dots

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PSCA PROTEIN, HUMAN; QUANTUM DOT; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; PROSTATE TUMOR;

ANTIGENS, NEOPLASM; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; QUANTUM DOTS;

EID: 84861535940     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s120505461     Document Type: Article

References (21)

1. Lalani, E.N.; Laniado, M.E.; Abel, P.D. Molecular and cellular biology of prostate cancer. Cancer Metastas. Rev. 1997, 16, 29-66.
2. Reiter, R.E.; Gu, Z.; Watabe, T.; Thomas, G.; Szigeti, K.; David, E.; Wahl, M.; Nisitani, S.; Yamashiro, J.; Le Beau, M.M.; et al. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA 1998, 95, 1735-1740.
3. Smith, A.M.; Duan, H.W.; Mohs, A.M.; Nie, S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug Deliv. Rev. 2008, 60, 1226-1240.
4. Alivisatos, A.P. Semiconductor clusters, nanocrystals, and quantum dots. Science 1996, 271, 933-937.
5. Nirmal, M.; Brus, L. Luminescence photophysics in semiconductor nanocrystals. Acc. Chem. Res. 1999, 32, 407-414.
6. Cozzoli, P.D.; Pellegrino, T.; Manan, L. Synthesis, properties, and perspectives of hybrid nanocrystal structures. Chem. Soc. Rev. 2006, 35, 1195-1208.
7. Medintz, I.L.; Uyeda, H.T.; Goldman, E.R.; Mattoussi, H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 2005, 4, 435-446.
8. Niemeyer, C.M. Nanoparticles, proteins, and nucleic acids: Biotechnology meets materials science. Angew. Chem. Int. Ed. Engl. 2001, 40, 4128-4158.
9. Smith, A.M.; Duan, H.W.; Mohs, A.M.; Nie, S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug. Deliv. Rev. 2008, 60, 1226-1240.
10. Wu, X.; Liu, H.; Liu, J.; Haley, K.N.; Treadway, J.A.; Larson, J.P.; Ge, N.; Peale, F.; Bruchez, M.P. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 2003, 21, 41-46.
11. Lidke, D.S.; Nagy, P.; Heintzmann, R.; Arndt-Jovin, D.J.; Post, J.N.; Grecco, H.E.; Jares-Erijman, E.A.; Jovin, T.M. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat. Biotechnol. 2004, 22, 198-203.
12. Gao, X.H.; Nie, S.M. Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol. 2003, 21, 371-373.
13. Kim, S.; Lim, Y.T.; Soltesz, E.G.; de Grand, A.M.; Lee, J.; Nakayama, A.; Parker, J.A.; Mihaljevic, T.; Laurence, R.G.; Dor, D.M.; et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004, 22, 93-97.
14. Smith, A.M.; Ruan, G.; Rhyner, M.N.; Nie, S. Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann. Biomed. Eng. 2006, 34, 3-14.
15. Shi, C.; Zhu, Y.; Cerwinka, W.H.; Zhau, H.E.; Marshall, F.F.; Simnos, J.W.; Nie, S.; Chung, L.W. Quantum dots: Emerging applications in urologic oncology. Urol. Oncol. Semin. Orig. Invest. 2008, 26, 86-92.
16. Tholouli, E.; Sweeney, E.; Barrow, E.; Clay, V.; Hoyland, J.A.; Byers, R.J. Quantum dots light up pathology. J. Pathol. 2008, 216, 275-285.
17. Chen, H.; Xue, J.; Zhang, Y.; Zhu, X.; Gao, J.; Yu, B. Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J. Mol. Histol. 2009, 40, 261-268.
18. Chen, C.; Peng, J.; Xia, H.; Wu, Q.; Zeng, L.; Xu, H.; Tang, H.; Zhang, Z.; Zhu, X.; Pang, D.; Li, Y. Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity. Nanotechnology 2010, 21, 095101.
19. Gleason, D.F.; Mellinger, G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 1974, 111, 58-64.
20. Beahrs, O.H.; Henson, D.E.; Hutter, R.V.P.; Kennedy, B.J. AJCC Manual for Staging of Cancer, 4th ed.; JB Lippincott Company: Philadelphia, PA, USA, 1992; p. 181.
21. Zhao, Z.G.; Shen, W. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer. Jpn. J. Clin. Oncol. 2006, 36, 121.